E-Paper | March 08, 2026

Haleon to increase Panadol production

The Newspaper's Staff Reporter Published July 30, 2025
comments
Whatsapp Channel

LAHORE: Haleon, a consumer healthcare company, announced on Tuesday that it is enhancing its production capacity of Panadol in Pakistan as part of a $12 million investment plan.

The initiative, laun­ch­ed in 2023 and set to be completed by the end of 2026, aims to strengthen the availability of the over-the-counter medicine.

Haleon CEO Qawi Naseer emphasised that the company’s focus is to empower people with accessible healthcare solutions.

During a ceremony, Mr Naseer further highlighted that Haleon’s demerger from GSK in 2022 has allowed for greater flexibility and autonomy to support local growth and innovation.

Published in Dawn, July 30th, 2025

Newspaper

Read more

Most Popular

01
02
03
04
05
06
07
08
09

Latest Stories

Opinion

Editorial

Petrol shock
Updated 08 Mar, 2026

Petrol shock

With oil markets bracing for more volatility, more price shocks are inevitable in the coming weeks.
Women’s Day
08 Mar, 2026

Women’s Day

IT is a simple truth: societies progress when women are able to shape them. Yet the struggle for equality has never...
Rescuing hockey
08 Mar, 2026

Rescuing hockey

PAKISTAN hockey is back to where it should be. Years of misses came to an end on Friday with a long-awaited...
Limiting the damage
Updated 07 Mar, 2026

Limiting the damage

Govt plan to revive a range of Covid-era steps reflect a recognition that early restraint can limit disruptive interventions.
Diplomatic option
07 Mar, 2026

Diplomatic option

WITH Operation Ghazab lil Haq underway for over a week now, Pakistan has demonstrated that it can take firm action...
Polio, again
07 Mar, 2026

Polio, again

ANOTHER child has fallen victim to polio, this time in Sindh. The National Institute of Health this week confirmed...
Dawn News English
Subscribe